Medicare Retiree Drug Subsidy Tax May Prompt Employer Coverage Shifts, Focus On Rx Costs
This article was originally published in The Pink Sheet Daily
Employer-sponsored drug coverage for retirees may change in the coming years as a result of the new tax of the Medicare retiree drug subsidy, signed into law as part of health reform.
You may also be interested in...
Business leaders are intensifying opposition to a provision in the House and Senate health care reform bills that would revise the tax treatment on the Medicare Part D subsidy for employers who provide retirees with prescription drug coverage
Agency cites possible demonstration in response to HHS Office of Inspector General report urging reimbursement reforms to spur greater use of biosimilars and lower costs for Medicare and beneficiaries.
Stakeholders differ on whether the rapid growth in spending is to be expected, given the realities in health care and specialty drug costs, or that the data underscores the need for oversight and reform of the 340B program.